Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells and Stromal Vascular Fraction Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial

NCT03164083 is registered in ClinicalTrials.gov with SCARM Institute, Tabriz, Iran as lead sponsor.

NCT NCT03164083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03164083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells and Stromal Vascular Fraction Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial
Lead sponsor
SCARM Institute, Tabriz, Iran
Phase
Phase 2
Overall status
Withdrawn
Start date
November 10, 2019
Completion date
December 5, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis